Stock P2AT34 UIPATH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus UiPath Inc. Sao Paulo

Equities

P2AT34

BRP2ATBDR004

Market Closed - Sao Paulo
Other stock markets
 20:54:41 26/06/2024 BST 		5-day change 1st Jan Change
8.45 BRL -31.13% Intraday chart for UiPath Inc. +9.17% -45.20%
06-21 Wells Fargo Adjusts Price Target on UiPath to $14 From $15, Maintains Equalweight Rating MT
06-06 Transcript : UiPath Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-06-2024 09:20 AM

Evolution of the average Target Price on UiPath Inc.

Price target over the last 5 years

History of analyst recommendation changes

230c34ede519c48281c46e938c6.Wgzh_xTSni8eNzTcsKUB-ZwqNxFfniQYEIpczZ1dpIc.Y3Wbm3qBp193RlDx-ss5gehmT183xxRJXPw1o_o21c8OU9WaTObOZGtvUw~dc740c6659254166fc7212ef7f6286b6

Analyst Recommendations on UiPath Inc.

Wells Fargo Adjusts Price Target on UiPath to $14 From $15, Maintains Equalweight Rating MT
BMO Capital Adjusts Price Target on UiPath to $14 From $28, Maintains Market Perform Rating MT
Macquarie Downgrades UiPath to Neutral From Outperform, Adjusts Price Target to $12 From $29 MT
BofA Securities Downgrades UiPath to Neutral From Buy, Cuts Price Target to $16 From $30; Shares Fall MT
Evercore ISI Cuts Price Target on UiPath to $13 From $27, Maintains In Line Rating MT
BofA Securities Downgrades UiPath to Neutral From Buy, Adjusts Price Target to $16 From $30 MT
Mizuho Adjusts Price Target on UiPath to $14 From $25, Maintains Neutral Rating MT
Needham Downgrades UiPath to Hold From Buy MT
William Blair Downgrades UiPath to Market Perform From Outperform MT
TD Cowen Downgrades UiPath to Hold From Buy, Price Target is $17 MT
RBC Cuts Price Target on UiPath to $19 From $24, Notes 'Execution Issues,' CEO Transition, Keeps Sector Perform Rating MT
Morgan Stanley Cuts Price Target on UiPath to $15 From $25, Calls Stock 'a Show-Me Story,' Keeps Equalweight Rating MT
Truist Downgrades UiPath to Hold From Buy After Disappointing Fiscal Q1 Results, Lowers Price Target to $14 From $32 MT
KeyBanc Downgrades UiPath to Sector Weight From Overweight, Removes $27 Price Target Amid Cut to Fiscal 2025 Guidance, CEO Resignation MT
Scotiabank Adjusts Price Target on UiPath to $25 From $30, Maintains Sector Perform Rating MT
RBC Lowers Price Target on UiPath to $24 From $29, Keeps Sector Perform Rating MT
UiPath Insider Sold Shares Worth $1,108,093, According to a Recent SEC Filing MT
Uipath Insider Sold Shares Worth $1,212,778, According to a Recent SEC Filing MT
KeyBanc Assumes UiPath at Overweight, Sets $27 Price Target, Sees UiPath Well-Positioned to Keep Driving Market Share Gains MT
Canaccord Genuity Raises Price Target on UiPath to $30 From $27, Maintains Buy Rating MT
Macquarie Raises Price Target on UiPath to $29 From $28 Citing Balanced Growth/Margin, Strong Cash Flows, Cloud ARR Momentum, Keeps Outperform Rating MT
Barclays Adjusts UiPath's Price Target to $25 From $23, Maintains Equalweight Rating MT
TD Cowen Adjusts UiPath's Price Target to $28 From $25, Maintains Outperform Rating MT
Evercore ISI Adjusts UiPath's Price Target to $27 From $24, Maintains In Line Rating MT
BMO Capital Raises Price Target on UiPath to $28 From $24, Maintains Market Perform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
12.22 USD
Average target price
16.19 USD
Spread / Average Target
+32.47%
High Price Target
26 USD
Spread / Highest target
+112.77%
Low Price Target
13 USD
Spread / Lowest Target
+6.38%

Consensus detail

Consensus revision (last 18 months)

Analysts covering UiPath Inc.

Wells Fargo Securities
BMO Capital
Macquarie
BofA Securities
Evercore ISI
Mizuho Securities
Needham & Co.
William Blair & Co.
TD Cowen
RBC Capital Markets
KeyBanc Capital Markets
Morgan Stanley
Truist Securities
Scotiabank
Canaccord Genuity
Barclays
DA Davidson
JPMorgan Chase
Credit Suisse
Oppenheimer
SMBC Nikko
Cowen
Berenberg Bank
Summit Insights Group
J.P. Morgan Chase
Wolfe Research

Ratings for UiPath Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PATH Stock
  4. P2AT34 Stock
  5. Consensus UiPath Inc.